新光药业 (300519.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

23.5x

Market Cap

CNY 2.25B

MomentumView details →

1D Return

−1.47%

YTD Return

−3.83%

RSI (14)

49.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

23.5x

Market Cap

CNY 2.25B

RSI (14)

49.9

MomentumView details →

1D Return

−1.47%

YTD Return

−3.83%

ProfitabilityView details →

Gross Margin

41.71%

Net Margin

21.51%

EBITDA Margin

30.55%

ROE (TTM)

6.48%

ROA (TTM)

6.08%

Asset Turnover

0.29x

GrowthView details →

Revenue YoY

+0.08%

EPS YoY

+6.96%

FCF YoY

+42.22%

Revenue CAGR 3Y

−8.94%

EPS CAGR 3Y

−20.63%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

16.38x

Quick Ratio

15.85x

Div Yield

2.09%

Div Rate

CNY 0.30

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

260.58M

Net Income (TTM)

56.04M

Op. CF (TTM)

78.90M

Latest newsMore news →

No recent news for 300519.SZ.

Similar companies

中哲精化000953.SZ 实丰文化002862.SZ 双箭股份002381.SZ 海泰科301022.SZ 恩威医药301331.SZ 蠡湖股份300694.SZ Find similar companies →

Latest newsMore news →

No recent news for 300519.SZ.